Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 145

1.

CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma.

Pannem RR, Dorn C, Ahlqvist K, Bosserhoff AK, Hellerbrand C, Massoumi R.

Carcinogenesis. 2014 Feb;35(2):461-8. doi: 10.1093/carcin/bgt335. Epub 2013 Oct 8.

PMID:
24104553
[PubMed - indexed for MEDLINE]
2.

Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells.

Urbanik T, Köhler BC, Boger RJ, Wörns MA, Heeger S, Otto G, Hövelmeyer N, Galle PR, Schuchmann M, Waisman A, Schulze-Bergkamen H.

Int J Oncol. 2011 Jan;38(1):121-31.

PMID:
21109933
[PubMed - indexed for MEDLINE]
3.

miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.

Li HP, Zeng XC, Zhang B, Long JT, Zhou B, Tan GS, Zeng WX, Chen W, Yang JY.

Carcinogenesis. 2013 Nov;34(11):2443-51. doi: 10.1093/carcin/bgt206. Epub 2013 Jun 5.

PMID:
23740840
[PubMed - indexed for MEDLINE]
4.

Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation.

Hui L, Zatloukal K, Scheuch H, Stepniak E, Wagner EF.

J Clin Invest. 2008 Dec;118(12):3943-53. doi: 10.1172/JCI37156. Epub 2008 Nov 6.

PMID:
19033664
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression.

Yin J, Ding J, Huang L, Tian X, Shi X, Zhi L, Song J, Zhang Y, Gao X, Yao Z, Jing X, Yang J.

Anat Rec (Hoboken). 2013 Oct;296(10):1568-75. doi: 10.1002/ar.22737. Epub 2013 Jul 22.

PMID:
23878061
[PubMed - indexed for MEDLINE]
6.

Inhibition of the proliferation and invasion of hepatocellular carcinoma cells by lipocalin 2 through blockade of JNK and PI3K/Akt signaling.

Lee EK, Kim HJ, Lee KJ, Lee HJ, Lee JS, Kim DG, Hong SW, Yoon Y, Kim JS.

Int J Oncol. 2011 Feb;38(2):325-33. doi: 10.3892/ijo.2010.854. Epub 2010 Dec 3.

PMID:
21132267
[PubMed - indexed for MEDLINE]
7.

Recombinant human adenovirus-p53 injection induced apoptosis in hepatocellular carcinoma cell lines mediated by p53-Fbxw7 pathway, which controls c-Myc and cyclin E.

Tu K, Zheng X, Zhou Z, Li C, Zhang J, Gao J, Yao Y, Liu Q.

PLoS One. 2013 Jul 1;8(7):e68574. doi: 10.1371/journal.pone.0068574. Print 2013.

PMID:
23840897
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Reduced expression of CYLD in human colon and hepatocellular carcinomas.

Hellerbrand C, Bumes E, Bataille F, Dietmaier W, Massoumi R, Bosserhoff AK.

Carcinogenesis. 2007 Jan;28(1):21-7. Epub 2006 Jun 13.

PMID:
16774947
[PubMed - indexed for MEDLINE]
Free Article
9.

SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma.

Tsao CM, Yan MD, Shih YL, Yu PN, Kuo CC, Lin WC, Li HJ, Lin YW.

Hepatology. 2012 Dec;56(6):2277-87. doi: 10.1002/hep.25933.

PMID:
22767186
[PubMed - indexed for MEDLINE]
10.

C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization.

Wu YM, Liu CH, Huang MJ, Lai HS, Lee PH, Hu RH, Huang MC.

Cancer Res. 2013 Sep 1;73(17):5580-90. doi: 10.1158/0008-5472.CAN-13-0869. Epub 2013 Jul 5.

PMID:
23832667
[PubMed - indexed for MEDLINE]
Free Article
11.

A potential role for the homeoprotein Hhex in hepatocellular carcinoma progression.

Su J, You P, Zhao JP, Zhang SL, Song SH, Fu ZR, Ye LW, Zi XY, Xie DF, Zhu MH, Hu YP.

Med Oncol. 2012 Jun;29(2):1059-67. doi: 10.1007/s12032-011-9989-6. Epub 2011 Jun 8.

PMID:
21656028
[PubMed - indexed for MEDLINE]
12.

JNK1, JNK2, and JNK3 are involved in P-glycoprotein-mediated multidrug resistance of hepatocellular carcinoma cells.

Yan F, Wang XM, Liu ZC, Pan C, Yuan SB, Ma QM.

Hepatobiliary Pancreat Dis Int. 2010 Jun;9(3):287-95.

PMID:
20525557
[PubMed - indexed for MEDLINE]
Free Article
13.

Leptin as a critical regulator of hepatocellular carcinoma development through modulation of human telomerase reverse transcriptase.

Stefanou N, Papanikolaou V, Furukawa Y, Nakamura Y, Tsezou A.

BMC Cancer. 2010 Aug 19;10:442. doi: 10.1186/1471-2407-10-442.

PMID:
20723213
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Clinical significance of PICT1 in patients of hepatocellular carcinoma with wild-type TP53.

Ishibashi M, Kogo R, Shibata K, Ueo H, Uchi R, Matsumura T, Takano Y, Sawada G, Takahashi Y, Mima K, Kurashige J, Akiyoshi S, Iwaya T, Eguchi H, Sudo T, Sugimachi K, Suzuki A, Wakabayashi G, Mori M, Mimori K.

Ann Surg Oncol. 2013 Dec;20 Suppl 3:S537-44. doi: 10.1245/s10434-013-2958-x. Epub 2013 Mar 27.

PMID:
23532381
[PubMed - indexed for MEDLINE]
15.

Lin-28B expression promotes transformation and invasion in human hepatocellular carcinoma.

Wang YC, Chen YL, Yuan RH, Pan HW, Yang WC, Hsu HC, Jeng YM.

Carcinogenesis. 2010 Sep;31(9):1516-22. doi: 10.1093/carcin/bgq107. Epub 2010 Jun 4.

PMID:
20525879
[PubMed - indexed for MEDLINE]
Free Article
16.

Functional interactions between retinoblastoma and c-MYC in a mouse model of hepatocellular carcinoma.

Saddic LA, Wirt S, Vogel H, Felsher DW, Sage J.

PLoS One. 2011 May 6;6(5):e19758. doi: 10.1371/journal.pone.0019758.

PMID:
21573126
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Inactivation of the deubiquitinase CYLD in hepatocytes causes apoptosis, inflammation, fibrosis, and cancer.

Nikolaou K, Tsagaratou A, Eftychi C, Kollias G, Mosialos G, Talianidis I.

Cancer Cell. 2012 Jun 12;21(6):738-50. doi: 10.1016/j.ccr.2012.04.026.

PMID:
22698400
[PubMed - indexed for MEDLINE]
Free Article
18.

Identification of LZAP as a new candidate tumor suppressor in hepatocellular carcinoma.

Zhao JJ, Pan K, Li JJ, Chen YB, Chen JG, Lv L, Wang DD, Pan QZ, Chen MS, Xia JC.

PLoS One. 2011;6(10):e26608. doi: 10.1371/journal.pone.0026608. Epub 2011 Oct 19.

PMID:
22028922
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.

Calvisi DF, Wang C, Ho C, Ladu S, Lee SA, Mattu S, Destefanis G, Delogu S, Zimmermann A, Ericsson J, Brozzetti S, Staniscia T, Chen X, Dombrowski F, Evert M.

Gastroenterology. 2011 Mar;140(3):1071-83. doi: 10.1053/j.gastro.2010.12.006. Epub 2010 Dec 11.

PMID:
21147110
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K/Akt pathway.

Tian T, Nan KJ, Guo H, Wang WJ, Ruan ZP, Wang SH, Liang X, Lu CX.

Oncol Rep. 2010 Jun;23(6):1593-600.

PMID:
20428814
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk